Feature Channels: Vaccines

Filters close
Newswise: Vaccines protected pregnant women during Omicron surge
Released: 27-Jan-2023 3:35 PM EST
Vaccines protected pregnant women during Omicron surge
University of Washington School of Medicine and UW Medicine

The main point of the study, which was completed before other variants came on the scene, is for pregnant women to get vaccinated and receive all their boosters, including the bivalent booster.

Newswise: COVID by the numbers at UCLA Health: A million tests; 300,000 vaccines; 55,000 patients
Released: 27-Jan-2023 11:55 AM EST
COVID by the numbers at UCLA Health: A million tests; 300,000 vaccines; 55,000 patients
University of California, Los Angeles (UCLA), Health Sciences

Three years ago this month, the first case of COVID was diagnosed in the United States. Here are the latest figures on the pandemic, collected by UCLA Health hospitals and clinics.

Released: 26-Jan-2023 9:05 AM EST
Investigadores de Mayo Clinic diseñan vacunas terapéuticas personalizadas para combatir el cáncer  
Mayo Clinic

Las vacunas han protegido a las personas de enfermedades mortales durante generaciones. ¿También podrían ayudar a combatir el cáncer? Los investigadores de Mayo Clinic están trabajando en el desarrollo de vacunas terapéuticas personalizadas contra el cáncer que podrían atacar las características distintivas de los tumores en cada persona.

Released: 26-Jan-2023 9:05 AM EST
Pesquisadores da Mayo Clinic desenvolvem vacinas terapêuticas personalizadas para combater o câncer  
Mayo Clinic

As vacinas protegem as pessoas contra doenças mortais ao longo de gerações, mas será que elas também poderiam ajudar a combater o câncer? Os pesquisadores da Mayo Clinic estão trabalhando para desenvolver vacinas terapêuticas personalizadas contra o câncer.

Newswise: National Primate Research Center of Thailand Chulalongkorn University Symposium 2023
Released: 26-Jan-2023 8:55 AM EST
National Primate Research Center of Thailand Chulalongkorn University Symposium 2023
Chulalongkorn University

As its 11th-anniversary approaches, the National Primate Research Center of Thailand Chulalongkorn University (NPRCT-CU) and the Primates Enterprise Co., Ltd. are pleased to announce two events in February 2023:

Released: 26-Jan-2023 12:05 AM EST
باحثو مايو كلينك يصممون لقاحات علاجية مخصصة لمكافحة السرطان
Mayo Clinic

جاكسونفيل، فلوريدا — لطالما حمت اللقاحات الناس من الأمراض الفتاكة لأجيال. فهل يمكنها أيضًا المساعدة في محاربة السرطان؟  يعمل باحثو مايو كلينك على تطوير لقاحات علاجية مخصصة للسرطان يمكنها استهداف خصائص الورم المميزة لكل شخص. إن هذا النهج الجديد، المبني على التقدم في الأبحاث الجينومية وتحليلات البيانات، يحمل إمكانات تحويلية لتعزيز قوة الجهاز المناعي للتعرف على الخلايا السرطانية ومهاجمتها. 

Released: 25-Jan-2023 4:55 PM EST
Corona vaccine based on new technology tested in clinical study
Radboud University Medical Centre Nijmegen

A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud university medical center.

Newswise:Video Embedded computer-model-of-influenza-virus-shows-universal-vaccine-promise
VIDEO
Released: 25-Jan-2023 12:35 PM EST
Computer Model of Influenza Virus Shows Universal Vaccine Promise
University of California San Diego

For the first time, researchers at UC San Diego have created an atomic-level computer model of the H1N1 virus that reveals new vulnerabilities, suggesting possible strategies for the design of future vaccines and antivirals against influenza.

   

Not for public release

This news release is embargoed until 30-Jan-2023 5:00 PM EST Released to reporters: 24-Jan-2023 2:20 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Jan-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Michael Criscuolo joins The Wistar Institute as Vice President of Development
Released: 24-Jan-2023 1:45 PM EST
Michael Criscuolo joins The Wistar Institute as Vice President of Development
Wistar Institute

The Wistar Institute, which has recently launched a $75 million programmatic campaign investing in biomedical advances, announces the appointment of Michael Criscuolo as Vice President of Development.

Released: 24-Jan-2023 6:05 AM EST
A design of experiments approach to precision vaccine adjuvants
Washington University in St. Louis

Adjuvants are added to vaccines to improve protection, extend the duration of protection and reduce the dose or number of boosters required.

Released: 23-Jan-2023 5:05 PM EST
Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the Future
Covid-19 Prevention Network (CoVPN)

The federally funded COVID-19 Prevention Network was instrumental in the rapid development of safe, effective and lifesaving COVID-19 vaccines during earlier phases of the pandemic. This vital work to expedite Phase 3 clinical trials also resulted in a 'treasure trove' of data, thanks to a highly collaborative and harmonized approach that can serve as a national and even international model for major research initiatives while also guiding responses to future public health emergencies.

Released: 23-Jan-2023 3:10 PM EST
Covid-19 in pregnant women can damage the placenta and the fetus
Medical University of Vienna (MedUni Wien)

Using prenatal magnetic resonance imaging, a group of MedUni Vienna researchers examined the placentas and foetuses of women who tested positive for SARS-CoV-2 during pregnancy.

Released: 19-Jan-2023 4:10 PM EST
500,000 missed out on blood pressure lowering drugs during pandemic
Health Data Research UK

Nearly half a million people missed out on starting medication to lower their blood pressure during the Covid-19 pandemic, according to research supported by the British Heart Foundation (BHF) Data Science Centre at Health Data Research UK published today in Nature Medicine [1].

Released: 18-Jan-2023 7:15 PM EST
COVID-19 symptoms 6 months after onset, role of vaccination for SARS-CoV-2 infection
JAMA - Journal of the American Medical Association

In this study of 1,832 U.S. adults, the risk of reporting symptoms for 28 or more days after COVID-19 onset was significantly higher in participants who were unvaccinated at the time of infection and those who reported moderate or severe acute illness symptoms.

Released: 18-Jan-2023 1:05 PM EST
Sharing vaccine intellectual property with global community could save millions of lives
Binghamton University, State University of New York

If pharmaceutical companies shared their intellectual property rights to vaccines with the global community, millions of lives could be saved in future pandemics, according to a new paper co-authored by faculty at Binghamton University, State University of New York.

Released: 18-Jan-2023 10:05 AM EST
Vaccination Provides Effective Protection Against Increased Risk of Pregnancy Complications due to COVID-19 Omicron Variant
Ann and Robert H. Lurie Children's Hospital of Chicago

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has published in the journal Lancet the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries, including Ann & Robert H. Lurie Children’s Hospital of Chicago.

Released: 18-Jan-2023 10:00 AM EST
Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review
HIV Vaccine Trials Network

A Phase 3 study of an investigational HIV vaccine regimen has been discontinued following a planned, interim review by the study’s independent Data and Safety Monitoring Board. The investigational vaccine was generally safe and well tolerated; however, it was not effective at preventing the acquisition of HIV-1. The results of the uniquely designed and implemented Mosaico study underscore the challenges that have faced the global scientific community in the 40-year search for an HIV vaccine, and may provide important data in the ongoing fight against HIV.

Released: 17-Jan-2023 7:05 PM EST
Vaccination gets a boost when people know their neighbors are doing it
University of Texas at Austin (UT Austin)

Just as a highly transmissible variant prompts officials to extend COVID-19 emergency status, one of the largest surveys ever conducted shows people are more willing to get vaccinated when health workers reveal how many others are doing so.

   
Released: 17-Jan-2023 12:45 PM EST
Mucosal antibodies in the airways provide durable protection against SARS-CoV-2
Karolinska Institute

High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months. Omicron infection generates durable mucosal antibodies, reducing the risk of re-infection.

Released: 17-Jan-2023 8:00 AM EST
Improving Adult Immunization Rates the Focus of Partnership Between ATS and Three Health Systems Across the U.S.
American Thoracic Society (ATS)

NEW YORK, NY – Jan. 17, 2023 – The American Thoracic Society is starting the new year poised to improve vaccination rates with three health system partners: University of Arizona/ Banner Health; West Virginia University Hospitals, Inc.; and San Francisco Health Network/ University of California.

Newswise: When battling multiple infections, infants and toddlers at higher risk of severe outcomes, study suggests
Released: 12-Jan-2023 3:00 PM EST
When battling multiple infections, infants and toddlers at higher risk of severe outcomes, study suggests
Beaumont Health

Results of the 18-month study, published in Lancet Regional Health - Americas and led by Amit Bahl, M.D., M.P.H., emergency medicine with Corewell Health East, formerly Beaumont Health, showed that while omicron cases had the highest hospital admission rates among children ages 0 to 17, serious, even deadly, cases of illness were less likely during omicron than during the delta and alpha variants. In fact, the odds of severe disease were 65% lower during omicron compared to alpha.

10-Jan-2023 9:35 AM EST
Scientists find more evidence that breast milk of those vaccinated against COVID-19 may protect infants
University of Florida

Findings from a newly published study provide further evidence suggesting that the breast milk of those vaccinated against COVID-19 may help protect babies from the illness

Released: 11-Jan-2023 7:40 PM EST
Annual or biannual boosters are optimal for fighting endemic COVID-19, study shows
Yale School of Public Health

While COVID-19 boosters have been found to protect against infection, hospitalization, and severe illness, the waning of their protection has led to uncertainty about when it is most appropriate to get an additional booster shot.

Released: 11-Jan-2023 11:40 AM EST
COVID-19: New research about how antibodies are formed
Friedrich-Alexander-Universität Erlangen-Nürnberg

A team of researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen has gained new insights into the maturation of SARS-CoV-specific antibodies after multiple vaccinations with the mRNA vaccine Comirnaty.

Released: 11-Jan-2023 11:00 AM EST
COVID-19 conspiracy theories among the UK Black community
Kingston University

A belief that COVID-19 was a myth created to control ethnic populations, or a virus created to eliminate the Black community were among the conspiracy theories that caused a lower engagement of health prevention methods among UK Black communities, research by Kingston University, London experts has shown.

   
Released: 10-Jan-2023 5:10 PM EST
Unraveling key determinant of successful therapeutic vaccination against chronic hepatitis B
Elsevier

Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments rarely succeed in curing the infection.

Newswise: Analysis: A Longer View on COVID-19 Antibodies
Released: 10-Jan-2023 3:00 PM EST
Analysis: A Longer View on COVID-19 Antibodies
Cedars-Sinai

A new analysis by Cedars-Sinai investigators is furthering the scientific community’s understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in different population groups.

Released: 10-Jan-2023 12:05 PM EST
Low concern and political distrust behind vaccine-resistance, new study finds
University of Kent

With a return to the workplace and school, the UK Health Security Agency recently warned that cases of flu and COVID-19 are expected to soar throughout January.

Newswise: Some forms of childhood malnutrition, stunting may be preventable with vaccines
Released: 9-Jan-2023 6:00 PM EST
Some forms of childhood malnutrition, stunting may be preventable with vaccines
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have discovered that vaccinating mice against a toxin produced by the bacterium E. coli can prevent intestinal damage, a finding that suggests new ways to prevent malnutrition and stunting in children.

Released: 9-Jan-2023 4:50 PM EST
COVID-19 vaccine acceptance increased globally in 2022
CUNY Graduate School of Public Health and Health Policy

Global willingness to accept a COVID-19 vaccine increased from 75.2% in 2021 to 79.1% in 2022, according to a new survey of 23 countries that represent more than 60% of the world’s population, published today in Nature Medicine.

Released: 9-Jan-2023 12:50 PM EST
Surge of SARS-CoV-2 Variants in China and USA Further Emphasizes Need for Surveillance, Preparedness, and International Collaborations
Global Virus Network

Christian Bréchot, MD, PhD, President of the Global Virus Network (GVN), Associate Vice President for International Partnerships and Innovation at the University of South Florida and Professor of the Division of Infectious Disease, Department of Internal Medicine at USF Health Morsani College of Medicine, the GVN Southeast U.S. Regional Headquarters today issued a statement on the surge of SARS-CoV-2.

Released: 6-Jan-2023 6:05 PM EST
Tip Sheet: New genetic risk factors identified for colorectal cancer, new challenge trial on a tuberculosis vaccine — and 2022 news highlights
Fred Hutchinson Cancer Center

Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. Interested in news you may have missed in 2022 from Fred Hutch?

Released: 6-Jan-2023 12:55 PM EST
Vaccine and prior SARS-CoV-2 infection confer long-lasting protection against omicron BA.5
Instituto de Medicina Molecular

A new study led by Luís Graça, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and full professor at the Medical School of the University of Lisbon, and Manuel Carmo Gomes, associate professor with aggregation at the Faculty of Sciences of the University of Lisbon (Ciências ULisboa), both members of the Direção Geral de Saúde (DGS) Technical Committee for Vaccination against COVID-19 (CTVC), and published today in the scientific journal Lancet Infectious Diseases*, shows that the protection conferred by hybrid immunity against the SARS-CoV-2 subvariant omicron BA.5, obtained by the infection of vaccinated people, lasts for at least eight months after the first infection.

Released: 4-Jan-2023 7:40 PM EST
Does COVID change the body’s response to other threats? Depends on your sex
Yale University

The long-term effects of infection on the immune system have long intrigued John Tsang, a Yale immunobiologist. After the body has faced down a pathogen, does the immune system return to the previous baseline? Or does a single infection change it in ways that alter how it will respond not only to a familiar virus but also to the next new viral or bacterial threat it faces?

Newswise: A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
Released: 4-Jan-2023 12:55 PM EST
A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
University of Maryland School of Medicine

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

Released: 3-Jan-2023 4:10 PM EST
Examination of COVID-19 vaccine reactions after multisystem inflammatory syndrome in children
JAMA - Journal of the American Medical Association

In this study of study of 385 patients ages 5 or older with a history of multisystem inflammatory syndrome in children (MIS-C), no serious adverse events were reported after COVID-19 vaccination.

Newswise: December Research Highlights
Released: 29-Dec-2022 5:45 PM EST
December Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine
Released: 28-Dec-2022 11:30 AM EST
UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine
UT Southwestern Medical Center

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against infection.

Newswise: COVID-19 booster increases durability  of antibody response, research shows
Released: 22-Dec-2022 2:40 PM EST
COVID-19 booster increases durability of antibody response, research shows
University of Virginia Health System

New research from the University of Virginia School of Medicine speaks to the benefits of a COVID-19 booster.

Released: 21-Dec-2022 10:05 AM EST
Especialista da Mayo Clinic explica por que é importante que as crianças sejam vacinadas contra o HPV
Mayo Clinic

Há mais de 100 variedades de papilomavírus humano (HPV), uma infecção viral que, normalmente causa verrugas. Porém, alguns tipos de HPV podem causar câncer no colo do útero, ânus, pênis, vagina, vulva e garganta.

Released: 21-Dec-2022 10:05 AM EST
Experta de Mayo Clinic explica la importancia de que los niños reciban la vacuna contra el virus del papiloma humano (VPH)
Mayo Clinic

Existen más de 100 variedades del virus del papiloma humano (HPV), que es una infección viral que normalmente causa verrugas. Sin embargo, algunos tipos de VPH pueden causar cáncer de cuello uterino, ano, pene, vagina, vulva y garganta.

Released: 21-Dec-2022 9:55 AM EST
Tis the season to manage stress: Winter holiday story ideas and expert commentary
Newswise

Here are some of the latest articles that have been added to the Winter Holidays channel on Newswise.

   
Released: 21-Dec-2022 9:00 AM EST
A Deepening Partnership: How CHLA and Macedonia Baptist Church Are Tackling Health Inequities in South L.A.
Children's Hospital Los Angeles

“A ZIP code should not determine the life expectancy nor the diseases that we get,” says Alejandro “Alex” Guerrero, Executive Director of the Macedonia Community Development Corporation.

Newswise: RUDN University virologists evaluated the effectiveness of hepatitis A vaccination
Released: 21-Dec-2022 6:05 AM EST
RUDN University virologists evaluated the effectiveness of hepatitis A vaccination
Russian Foundation for Basic Research

RUDN University virologists measured the level of herd immunity to hepatitis A virus in different regions of Russia. The results make it possible to assess the effectiveness of the vaccination program. The study showed that mass vaccination should be introduced in all regions

Released: 21-Dec-2022 12:05 AM EST
خبير من مايو كلينك يشرح أهمية حصول الأطفال على لقاح فيروس الورم الحليمي البشري
Mayo Clinic

هناك أكثر من 100 نوع من فيروس الورم الحليمي البشري (HPV)، وهو عدوى فيروسية شائعة عادة ما تسبب البثور، إلا إن بعض أنواع فيروس الورم الحليمي البشري قد تسبب سرطانات في عنق الرحم، والشرج، والقضيب، والمهبل، والفرج، والحلق.

Released: 20-Dec-2022 7:55 PM EST
Chinese Communist Party zero-covid “volunteers” have suffered from stress and anxiety, study shows
University of Exeter

“Volunteers” tasked with enforcing the Chinese Communist Party’s zero-covid policies have suffered from stress and anxiety, a new study shows.


Showing results

150 of 3083

close
1.14471